Overview
Retail Trade

AIN HOLDINGS INC.

AIN Holdings operates Japan's leading network of dispensing pharmacies (調剤薬局) under the 'AIN Pharmacy' brand, with over 1,100 locations primarily situated within or adjacent to hospitals and medical facilities nationwide. The company's core Pharmacy segment handles insurance-based prescription dispensing, pharmaceutical wholesale (generics), and healthcare recruitment/consulting services through subsidiaries including AIN Pharmacies and Mediwell. Its Retail segment operates cosmetics-focused drug stores under the 'AINZ & TULPE' brand, and following the 2024 acquisition of Francfranc, has expanded into furniture and interior goods design, manufacturing, and sales.

Market Cap
¥196B
US$1.25B
EV
¥304B
US$1.94B
Stock¥5,585▼-1.05%
US$1 = ¥157.05 (2026-10-22)
LTM EV/EBITDA
7.3
x
LTM EV/EBIT
10.1
x
LTM PER
11.4
x
LTM PBR
1.2
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-39.1%pt
10012345
Oct 23, 25 – Oct 23, 26StockTOPIX
1May 8, 26Oasis Management Company Ltd. changed stake (14.89%→16.68%)
2Jun 29, 26Oasis Management Company Ltd. changed stake (16.68%→17.74%)
3Jul 28, 26Oasis Management Company Ltd. changed stake (17.74%→18.75%)
4Aug 14, 26Oasis Management Company Ltd. changed stake (19.8%→20.93%)
5Aug 20, 26Oasis Management Company Ltd. changed stake (20.93%→21.96%)
MC → EV Bridge
196BUS$1.25BMarket Cap167BUS$1.06B+ Debt54.3BUS$346M− Cash4.60BUS$29.3M− Inv. Sec.0.16BUS$1.03M+ NCI304BUS$1.94BEV
AI Briefing
Japan's largest dispensing pharmacy chain (1,100+ AIN Pharmacy sites), diversifying via AINZ & TULPE cosmetics and the 2024 Francfranc lifestyle goods acquisition. FY26/4 revenue ¥648B with OP ¥29.8B (4.6% margin), a step-change from FY25/4's ¥457B/¥16.9B, though margins remain below FY24/4 peak of 5.1%. Oasis funds hold a combined ~12.9% stake alongside Seven & i's 7.78%, keeping activist and strategic-alignment pressure on capital allocation and segment focus.
Performance & Balance
Revenue 5Y (¥B)
316US$2.01B'22/4359US$2.28B'23/4400US$2.55B'24/4457US$2.91B'25/4648US$4.13B'26/4
EBITDA 5Y (¥B)
19.9US$127M'22/421.5US$137M'23/426.9US$171M'24/425.2US$161M'25/440.9US$261M'26/4
Net Income 5Y (¥B)
7.09US$45.2M'22/49.23US$58.8M'23/411.4US$72.6M'24/49.26US$59.0M'25/417.3US$110M'26/4
Capital Structure
49%
51%
EquityD/E 1.06xDebt
Liquidity vs Debt 5Y (¥B)▼ Net Debt
CashInv. Sec.Debt
62.2US$396M8.47US$53.9M'22/449.5US$315M8.72US$55.5M'23/452.0US$331M6.73US$42.9M'24/430.1US$192M38.7US$247M'25/455.6US$354M172US$1.09B'26/4
Shareholders
Top 10 hold 54.5%
1
Kiichi OTANI
9.18%
2
Seven & i Holdings Co., Ltd.
7.78%
3
OASIS JAPAN STRATEGIC FUND LTD. (Standing Proxy: Citibank, N.A., Tokyo Branch)
7.45%
4
The Master Trust Bank of Japan, Ltd. (Trust Account)
6.29%
5
OASIS INVESTMENTS II MASTER FUND LTD. (Standing Proxy: Citibank, N.A., Tokyo Branch)
5.41%
6
North Pacific Bank,Ltd.
4.93%
7
Mizuho Trust & Banking Co., Ltd. (Retirement Benefit Trust, Marubeni Corporation Account; Re-trustee: Custody Bank of Japan, Ltd.)
4.51%
8
The Hokkaido Bank, Ltd.
4.17%
9
Morgan Stanley MUFG Securities Co., Ltd.
2.53%
10
Nomura Securities Co., Ltd.
2.24%
Management
14 officers
Kiichi OTANI
Representative Director, President
Jul 1980: Representative Director, President, Ohtani Co., Ltd. (now the Company) Nov 1981: Established Daiichi Rinsho Kensa Center Co., Ltd. (Asahikawa; now the Company); Director Jul 1983: Representative Director, President, Daiichi Rinsho Kensa Center Co., Ltd. May 1985: Managing Director, the Company May 1988: Representative Director, President, the Company (current)
1951-07-19
Shoichi SHUTO
Representative Director, Senior Managing Director; in charge of Development and Pharmacy Operations Oversight
Mar 1982: Joined Daiichi Rinsho Kensa Center Co., Ltd. (Asahikawa; now the Company) May 1991: General Manager, Corporate Planning Office, the Company Jul 2000: Director, the Company May 2003: Managing Director, the Company May 2004: General Manager, Pharmacy Business Division, the Company May 2012: Senior Managing Director, the Company Nov 2015: Representative Director, Senior Managing Director, the Company (current); in charge of Development May 2020: Chairman, National Pharmacy Association of Japan (NPhA) Nov 2023: Representative Director, President, Ain Pharmaciez, Inc. (current) May 2024: In charge of Development and Pharmacy Operations Oversight, the Company (current)
1959-11-16
Toshihide MIZUSHIMA
Representative Director, Senior Managing Director; in charge of Business Support and DX Strategy; General Manager, Retail Operations Division
Apr 1986: Joined Ohtani Co., Ltd. (now the Company) May 2000: General Manager, Drugstore Department, Merchandise Sales Division, the Company Jul 2000: Director, the Company Feb 2001: General Manager, Merchandise Sales Division, the Company May 2003: Managing Director, the Company May 2012: Senior Managing Director; General Manager, Administration Division, the Company Nov 2012: Representative Director, President, Wholesale Stars Co., Ltd. (current) Nov 2015: Representative Director, Senior Managing Director, the Company; in charge of Operations and Business Support Jul 2018: In charge of Operations, Business Support and IT, the Company Oct 2024: In charge of Business Support and Digital Promotion; General Manager, Retail Operations Division, the Company (current) May 2026: In charge of Business Support and DX Strategy, the Company (current)
1960-03-10
Rieko KIMEI
Director; General Manager, Human Resources Division
Dec 1995: Joined Daiichi Rinsho Kensa Center Co., Ltd. (Sapporo; now the Company) May 2003: General Manager, Merchandise Department, Merchandise Sales Division, the Company May 2004: General Manager, Human Resources Department, Administration Division, the Company May 2009: General Manager, Merchandise Sales Division; General Manager, Merchandise Department, the Company Jul 2014: Director, the Company (current) Jul 2016: Representative Director, President, Ayurra Laboratories Co., Ltd. Feb 2018: Director, Ain Pharmaciez, Inc. (current) Jul 2018: In charge of Human Resources, the Company May 2022: General Manager, Human Resources Division, the Company (current)
1962-02-26
Nobuyuki TAKAKURA
Director; General Manager, Sustainability Promotion Division
Apr 1981: Joined Ministry of Health and Welfare (now Ministry of Health, Labour and Welfare) Aug 2002: Director, Economic Affairs Division, Medical Affairs Bureau, Ministry of Health, Labour and Welfare Jul 2004: Director, Pension Division, Pension Bureau, Ministry of Health, Labour and Welfare Aug 2007: Director, General Affairs Division, Equal Employment, Children and Families Bureau, Ministry of Health, Labour and Welfare Jul 2009: Director, International Affairs Division, Minister's Secretariat, Ministry of Health, Labour and Welfare Jul 2010: Counselor, Minister's Secretariat, Ministry of Internal Affairs and Communications (in charge of Public Enterprises) Jul 2011: Counselor, Fire and Disaster Management Agency, Ministry of Internal Affairs and Communications Sep 2012: Director-General for Pension Administration, Minister's Secretariat, Ministry of Health, Labour and Welfare Jul 2013: Retired from Ministry of Health, Labour and Welfare Oct 2013: Special Advisor, Teijin Limited Apr 2014: Group Executive Officer; Assistant to Chief CSR Officer (special assignment), Teijin Group Apr 2016: Group Executive Officer; Chief CSR Officer, in charge of Business Sites Utilization, and Audit Department, Teijin Group Apr 2017: Group Executive Officer; in charge of CSR and Audit Department, Teijin Group Apr 2019: Advisor (part-time), Teijin Limited Apr 2020: Advisor, the Company Jul 2020: Senior Managing Director, Ain Pharmaciez, Inc. (current) Jul 2023: Director, the Company (current); in charge of Risk Management May 2025: General Manager, Sustainability Promotion Division, the Company (current)
1957-01-14
Noriko ENDO
Outside Director
Jun 1994: Joined Diamond, Inc. Mar 2006: Deputy Editor-in-Chief, Weekly Diamond Editorial Department, Diamond, Inc. Sep 2013: Visiting Research Fellow, Policy Vision Research Center, The University of Tokyo Apr 2015: Project Professor, Graduate School of Media and Governance, Keio University Jul 2018: Outside Director, the Company (current) Jun 2019: Outside Director, Hankyu Hanshin Holdings, Inc. (current) Apr 2020: Project Professor, Global Research Institute, Keio University Jun 2021: Outside Director, Japan Elevator Service Holdings Co., Ltd. (current) Jun 2022: Outside Director, Nippon Telegraph and Telephone Corporation (now NTT, Inc.) (current) Apr 2024: Professor, Waseda University (current)
1968-05-06
Hideki KURIYAMA
Outside Director
Apr 2004 Associate Professor, Hakuoh University Apr 2008 Professor, Hakuoh University (current) Nov 2011 Manager, Hokkaido Nippon-Ham Fighters Nov 2021 Manager, Japan National Baseball Team Jan 2022 Professor, Hokkaido Nippon-Ham Fighters Apr 2022 Specially Appointed Professor, Hokkai Gakuen University (current) Jul 2022 Outside Director of the Company (current) Jan 2024 Chief Baseball Officer, Hokkaido Nippon-Ham Fighters (current)
1961-04-26
Mariko WATAHIKI
Outside Director
Apr 1980: Assistant Judge, Tokyo District Court Mar 2009: Senior Investigating Officer (Civil), Supreme Court Mar 2012: President, Utsunomiya District Court Jul 2014: President, Yokohama Family Court Jun 2015: Judge (Division Head), Tokyo High Court Apr 2016: President, Sapporo High Court Sep 2018: President, Nagoya High Court Aug 2020: Registered as attorney-at-law Aug 2020: Joined Okamura Sogo Law Office (current) Jun 2021: Outside Director, Toshiba Corporation Jun 2021: Outside Director, LIXIL Corporation; Member, Nomination Committee and Governance Committee Jun 2022: Outside Director, LIXIL Corporation; Member, Nomination, Governance and Compensation Committees Oct 2022: Chair, Expert Committee, Daiko Advertising Inc. Jun 2023: Outside Director, LIXIL Corporation; Chair, Compensation Committee; Member, Nomination and Governance Committees Aug 2023: Chair, Third-Party Investigation Committee, Nihon University Jun 2024: Outside Director, LIXIL Corporation; Chair, Nomination Committee; Member, Compensation and Governance Committees (current) Jun 2024: Chairperson, Family Problems Information Center (FPIC) (current) Jul 2024: Outside Director, the Company (current)
1955-05-02
Nobutatsu HATTORI
Outside Director
Apr 1981: Joined Nissan Motor Co., Ltd. Jun 1989: Joined Goldman Sachs & Co., New York Headquarters Nov 1998: Managing Director, Goldman Sachs Securities Co., Ltd. (now Goldman Sachs Securities Co., Ltd.) Oct 2003: Visiting Associate Professor, Graduate School of International Corporate Strategy, Hitotsubashi University Nov 2005: Outside Director, Fast Retailing Co., Ltd. Oct 2006: Visiting Professor, Graduate School of International Corporate Strategy, Hitotsubashi University Apr 2009: Visiting Professor, Graduate School of Finance, Waseda University (now Graduate School of Business and Finance) (current) Jun 2015: Outside Director, Hakuhodo DY Holdings Inc. (current) Jul 2016: Specially Appointed Professor, Graduate School of Business Administration, Keio University Apr 2017: Visiting Professor, Graduate School of Business Administration, Keio University (current) Jul 2024: Outside Director, the Company (current) Nov 2025: Director, Tadashi Yanai Foundation (current)
1957-12-25
Shigeki KIMURA
Outside Director
Mar 1986: Joined Seven-Eleven Japan Co., Ltd. May 2013: General Manager, Accounting Management Division; Director, Corporate Conduct Promotion Office, Seven-Eleven Japan Co., Ltd. Mar 2014: Executive Officer, Seven-Eleven Japan Co., Ltd. May 2016: Senior Officer, Secretariat, Seven & i Holdings Co., Ltd. Dec 2016: Executive Officer; Senior Officer, Business Management Department, Seven & i Holdings Co., Ltd. Jul 2017: Outside Director, the Company Mar 2019: General Manager, Human Resources Planning Division, Seven & i Holdings Co., Ltd.; Director, Seven-Eleven Japan Co., Ltd. May 2019: Director, Seven & i Holdings Co., Ltd. Jul 2019: Retired as Outside Director, the Company Mar 2020: In charge of Group Company Governance, Seven & i Holdings Co., Ltd.; Managing Executive Officer and General Manager, Administration Division, Seven-Eleven Japan Co., Ltd. Apr 2020: In charge of President's Office and Group Coordination, Seven & i Holdings Co., Ltd. Mar 2024: Director; Senior Managing Director and General Manager, Administration Division, Seven-Eleven Japan Co., Ltd. Jul 2024: Outside Director, the Company (current) May 2025: Representative Director, Senior Managing Director, Seven & i Holdings Co., Ltd. (current); Director, Seven-Eleven Japan Co., Ltd. (current)
1962-03-16
Mamoru OOKI
Audit & Supervisory Board Member
Apr 1986: Joined Ohtani Co., Ltd. (now the Company); Merchandise Sales Division (now Retail Business) May 1995: Pharmacy Business Division (now Pharmacy Business), the Company Aug 2008: Deputy General Manager, Internal Audit Office (now Management Audit Office), the Company Jun 2019: General Manager, Internal Audit Office, the Company May 2022: Advisor, the Company Jul 2025: Full-time Audit & Supervisory Board Member, the Company (current); Audit & Supervisory Board Member, Ain Pharmaciez, Inc. (current)
1961-01-31
Tomiko TAWARAGI
Outside Director
Apr 1981: Joined Ministry of Health and Welfare (now Ministry of Health, Labour and Welfare) Sep 2006: Director, Medical Device Examination Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Jul 2009: Director, Standards and Examination Division, Food Safety Department, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Jul 2010: Director, Safety Measures Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Jul 2013: Senior Executive Director (Medical Device Examination), Pharmaceuticals and Medical Devices Agency (PMDA) Jul 2014: Chief Safety Officer, PMDA Jun 2016: Executive Advisor for Organizational Management, PMDA Jul 2018: Retired from Ministry of Health, Labour and Welfare Nov 2018: Chairperson, Association for Proper Use of Medicines (current) Mar 2020: Outside Director, Otsuka Medical Device Co., Ltd. (current) Jul 2025: Outside Audit & Supervisory Board Member, Ain Pharmaciez, Inc. Jul 2026: Scheduled to assume office as Outside Director, the Company
1958-06-22
Ayako SANO
Audit & Supervisory Board Member
Apr 2001: Joined Goldman Sachs Securities Co., Ltd. (now Goldman Sachs Securities Co., Ltd.) Dec 2008: Registered as attorney-at-law Jan 2009: Joined Tokyo Nishi Law Office (now TNLAW Law Corporation) Oct 2018: Judicial Mediation Officer, Tokyo District Court Dec 2018: Representative, Aya Sogo Law Office (current) Mar 2019: Outside Director, Skylark Holdings Co., Ltd. (current) Mar 2024: Outside Director, Sodick Co., Ltd. (current) May 2024: Outside Audit & Supervisory Board Member, CLASS, Inc. (current) Jun 2024: Auditor, Research Institute of Economy, Trade and Industry (RIETI) (current) Jul 2024: Outside Audit & Supervisory Board Member, the Company (current)
1977-12-09
Minako MIZUTANI
Audit & Supervisory Board Member
Apr 1995: Joined Masanori Otsubo Tax Accountant Office Jun 1998: Joined Ishiwatari, Nishimura & Nakane Joint Office (now Moore Shisei Tax Corporation) Oct 1998: Registered as tax accountant Sep 2011: Joined Tokyo Kyodo Accounting Office Apr 2013: Joined Seishin Tax Corporation (now Moore Shisei Tax Corporation) Sep 2016: Partner, Moore Shisei Tax Corporation Jun 2020: Outside Audit & Supervisory Board Member, The Yamanashi Chuo Bank, Ltd. (current) Sep 2023: Managing Partner, Moore Shisei Tax Corporation (current) Jul 2024: Outside Audit & Supervisory Board Member, the Company (current)
1969-09-24
Large Shareholding Reports
Sprucegrove Investment Management Ltd.
2026-09-11
5.86%→4.85%
Oasis Management Company Ltd.
2026-08-20
20.93%→21.96%
Oasis Management Company Ltd.
2026-08-20
21.96%→22.24%
Oasis Management Company Ltd.
2026-08-14
19.80%→20.93%
Oasis Management Company Ltd.
2026-08-05
18.75%→19.80%
Oasis Management Company Ltd.
2026-07-28
17.74%→18.75%
Oasis Management Company Ltd.
2026-06-29
16.68%→17.74%
Nomura Securities Co., Ltd.
2026-06-22
2.61%→2.94%
Annual report (as of 2026-04-30): 2.24%
Nomura Securities Co., Ltd.
2026-06-03
2.59%→2.61%
Annual report (as of 2026-04-30): 2.24%
Nomura Securities Co., Ltd.
2026-05-21
2.55%→2.59%
Annual report (as of 2026-04-30): 2.24%
Nomura Securities Co., Ltd.
2026-05-12
2.55%
Annual report (as of 2026-04-30): 2.24%
Oasis Management Company Ltd.
2026-05-08
14.89%→16.68%
Sprucegrove Investment Management Ltd.
2026-02-24
6.92%→5.86%
Sprucegrove Investment Management Ltd.
2025-09-19
7.99%→6.92%
Oasis Management Company Ltd.
2024-05-01
9.60%→14.89%
Oasis Management Company Ltd.
2024-03-06
9.60%
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-09-14
Q1 Earnings Flash
FY ending Apr 2027
EDINET
2026-09-11
Large Shareholding Report
EDINET
2026-08-20
Large Shareholding Report
EDINET
2026-08-20
Large Shareholding Report
EDINET
2026-08-14
Large Shareholding Report
EDINET
2026-08-05
Large Shareholding Report
EDINET
2026-07-29
Annual Securities Report
Period: May 2025 – Apr 2026
EDINET
2026-07-28
Large Shareholding Report
EDINET
2026-06-29
Large Shareholding Report
EDINET
2026-06-22
Large Shareholding Report
EDINET
2026-06-03
Large Shareholding Report
EDINET
2026-05-21
Large Shareholding Report
EDINET
2026-05-12
Large Shareholding Report
EDINET
2026-05-08
Large Shareholding Report
TDnet
2026-03-17
Q3 Earnings Flash
FY ending Apr 2026
EDINET
2026-02-24
Large Shareholding Report
EDINET
2025-12-15
Semi-Annual Securities Report
Period: May 2025 – Apr 2026
EDINET
2025-09-19
Large Shareholding Report
TDnet
2025-09-11
Q1 Earnings Flash
FY ending Apr 2026
EDINET
2025-07-31
Annual Securities Report
Period: May 2024 – Apr 2025
TDnet
2025-03-10
Q3 Earnings Flash
FY ending Apr 2025
EDINET
2024-12-13
Semi-Annual Securities Report
Period: May 2024 – Apr 2025
TDnet
2024-09-04
Q1 Earnings Flash
FY ending Apr 2025
EDINET
2024-07-31
Annual Securities Report
Period: May 2023 – Apr 2024
EDINET
2024-05-01
Large Shareholding Report
EDINET
2024-04-03
Securities Registration Statement
EDINET
2024-03-15
Quarterly Securities Report
Period: Nov 2023 – Jan 2024
EDINET
2024-03-06
Large Shareholding Report
EDINET
2023-12-15
Quarterly Securities Report
Period: Aug 2023 – Oct 2023
EDINETAmended
2023-11-15
Amended Annual Securities Report
Period: May 2022 – Apr 2023
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →